Pharmaceutical

SmartCella gains rights to advance cell therapy research for Parkinson’s

SmartCella has secured exclusive rights to advance research around cell replacement therapies for the treatment of Parkinson's.

Feb 15, 2025 - 06:00
SmartCella gains rights to advance cell therapy research for Parkinson’s
SmartCella has secured exclusive rights to advance research around cell replacement therapies for the treatment of Parkinson's.
Read the original article

Tags:

Previous Article

Trump presidency signals potential downturn in NIH SBIR/STTR grant funding for b...

Next Article

Bristol Myers Cuts Off Allergy Asset In Spite of Phase 3 Victory

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: FDA withdraws approval of controversial drug to prevent preterm births

STAT+: FDA withdraws approval of controversial drug to ...

Apr 7, 2023

M&A in pharmaceutical in France increased in Q2 2023

Jul 27, 2023

Teikoku Pharma bags FDA fast track for post-surgical transdermal analgesic  

Teikoku Pharma bags FDA fast track for post-surgical tr...

Jun 21, 2023